Advertisement

Pressure BioSciences, Inc. PBIO

Set alert

Price alert · PBIO

All alert types
0.00 USD 0.00 0.00%

At close · Oct 29

0.0398 Day range 0.0398
0.0001 52-week range 0.005
YTD
0.00%
1 year
-37.50%
Open
0.0398
Prev close
0.0005
Mkt cap
20.48K
Vol
800
Avg vol
5.97K
EPS
-0.95
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0398
High
0.0398
Forward P/E
0.00
Beta
2.21
Short ratio
3.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
Dec 23, 2024
50-d avg
4.00
200-d avg
6.37
1y target
1.57

2Y chart

Chart tools
Interval

Events in this range
  • Dec 23, 2024Earnings: —; estimate 0; surprise —%
Signals (74)
NameDateAgo
SMA: BearishOct 30, 20261 day ago
MACD: Sell SignalOct 30, 20261 day ago
RSI: OversoldOct 30, 20261 day ago
SMA: BullishOct 8, 20263 weeks ago
MACD: Buy SignalSep 17, 20261 month ago
MACD: Sell SignalSep 10, 20261 month ago
MACD: Buy SignalAug 27, 20262 months ago
MACD: Sell SignalJul 27, 20263 months ago
SMA: BearishJul 22, 20263 months ago
SMA: BearishJul 22, 20263 months ago
SMA: BullishJul 20, 20263 months ago
SMA: BullishJul 20, 20263 months ago
MACD: Buy SignalJul 20, 20263 months ago
RSI: OverboughtJul 20, 20263 months ago
MACD: Sell SignalJul 17, 20263 months ago
MACD: Buy SignalJul 15, 20263 months ago
RSI: OversoldJul 10, 20263 months ago
SMA: BearishJun 23, 20264 months ago
MACD: Sell SignalJun 23, 20264 months ago
MACD: Buy SignalJun 9, 20264 months ago
SMA: BullishMay 27, 20265 months ago
SMA: BullishMay 27, 20265 months ago
MACD: Sell SignalMay 14, 20265 months ago
SMA: BearishMay 13, 20265 months ago
SMA: BearishMay 13, 20265 months ago
RSI: OverboughtMay 6, 20265 months ago
SMA: BullishMay 5, 20265 months ago
SMA: BullishMay 5, 20265 months ago
MACD: Buy SignalMay 5, 20265 months ago
SMA: BearishApr 21, 20266 months ago
SMA: BearishApr 21, 20266 months ago
RSI: OversoldApr 21, 20266 months ago
MACD: Sell SignalApr 20, 20266 months ago
SMA: BullishMar 27, 20267 months ago
SMA: BullishMar 27, 20267 months ago
MACD: Buy SignalMar 27, 20267 months ago
RSI: OverboughtMar 27, 20267 months ago
MACD: Sell SignalMar 23, 20267 months ago
RSI: OversoldMar 23, 20267 months ago
SMA: BearishFeb 23, 20268 months ago
SMA: BullishFeb 19, 20268 months ago
SMA: BearishJan 21, 20269 months ago
SMA: BullishJan 20, 20269 months ago
MACD: Buy SignalNov 26, 202511 months ago
MACD: Sell SignalOct 29, 20251 year ago
SMA: BearishOct 27, 20251 year ago
SMA: BearishOct 27, 20251 year ago
SMA: BullishOct 23, 20251 year ago
MACD: Buy SignalOct 23, 20251 year ago
RSI: OverboughtOct 23, 20251 year ago
MACD: Sell SignalOct 20, 20251 year ago
SMA: BullishOct 2, 20251 year ago
MACD: Buy SignalAug 18, 20251 year ago
MACD: Sell SignalJul 29, 20251 year ago
SMA: BearishJul 24, 20251 year ago
SMA: BullishJul 23, 20251 year ago
RSI: OverboughtJul 23, 20251 year ago
MACD: Buy SignalJul 21, 20251 year ago
MACD: Sell SignalJul 11, 20251 year ago
SMA: BearishJul 10, 20251 year ago
SMA: BullishJul 9, 20251 year ago
MACD: Buy SignalJul 9, 20251 year ago
MACD: Sell SignalJul 3, 20251 year ago
MACD: Buy SignalJul 2, 20251 year ago
RSI: OversoldJun 25, 20251 year ago
MACD: Sell SignalJun 11, 20251 year ago
RSI: OversoldJun 11, 20251 year ago
MACD: Buy SignalMay 1, 20251 year ago
SMA: BearishApr 2, 20251 year ago
RSI: OversoldApr 2, 20251 year ago
MACD: Sell SignalMar 6, 20251 year ago
MACD: Buy SignalFeb 10, 20251 year ago
RSI: OverboughtFeb 10, 20251 year ago
MACD: Sell SignalJan 21, 20251 year ago

Key statistics

Market cap
4.94M
Enterprise value
14.11M
Trailing P/E
-1.19
Forward P/E
0.00
PEG ratio
0.00
Price / sales
2.41
Price / book
0.00
EPS (TTM)
-3.77
Beta
2.21
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-190.38%
Revenue (TTM)
2.05M
Revenue growth
5.80%
Free cash flow
-3.48M
Total cash
201.33K
Total debt
9.69M
Return on equity
0.00%
Shares outstanding
1.10M
Short % of float
4.56%
50-day average
4.00
200-day average
6.37

Analyst view

Consensus: none

Price target (mean) 1.57

Next earnings

Dec 23, 2024

Expected Dec 23, 2024. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
PBIO Revenue — quarterly 413.01K
2019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 2023
PBIO Net income — quarterly -5.63M
2019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 2023
PBIO EPS — quarterly -0.29
2019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 2023

Earnings

PBIO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 23, 2024Sep 1, 20240.00———
Sep 30, 2024Jun 1, 20240.00———
Sep 6, 2024Mar 1, 20240.00-0.22——
Jun 7, 2024Dec 1, 20230.00-0.30——
Nov 20, 2023Sep 1, 20230.00-0.29——
Aug 21, 2023Jun 1, 20230.00-0.57——

Upgrades / downgrades

PBIO analyst upgrades and downgrades
DateFirmActionFromTo
Aug 7, 2013Merriman Capitalinit—Speculative Buy

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. develops pressure cycling technology (PCT) solutions in the United States. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler NEP3229, HUB440, HUB880, and The Shredder SG3. It also distributes Constant Systems cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT-MicroCaps, PCT-Micro-Pestle, and BaroFlex 8-well Processing Strips, as well as application specific kits. Pressure BioSciences, Inc. serves researchers at academic laboratories; government agencies; and biotechnology, pharmaceutical, and other life sciences institutions. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.

Sector
Healthcare
Industry
Medical Appliances & Equipment
Country
United States

News

Your note

Sign in to keep a note on PBIO — it syncs with the Stock Master app.

Advertisement